Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Objective effects of dexamphetamine and amobarbital and their relations to psychasthenic personality traits

  • 27 Accesses

  • 11 Citations

Abstract

Objective effects of 5 and 15 mg dexamphetamine and 150 and 300 mg amobarbital were studied in two groups of 22 military subjects, selected on the basis of extreme scores on a Psychasthenia scale. Blood pressure, pulse rate and performance on psychomotor, perceptual and cognitive tests were measured before, one hour and two hours after intake of capsules containing a drug dose or placebo. The drug conditions were rotated and the procedure was double-blind.

The general pattern of drug effects was as expected; improvement after dexamphetamine and impairment after amobarbital, when compared to placebo. This pattern was illustrated as reflecting an activation continuum, the lowest activation being noted on 300 mg amobarbital and the highest on 15 mg dexamphetamine.

Dexamphetamine gave few significant effects except for the cardiovascular measures. Significant effects were obtained after amobarbital in a number of tests.

The treatment-group interactions noted appeared to be related to a greater sensitivity to amobarbital in the High Psychasthenia group. More significant effects were obtained after amobarbital as compared to placebo in this group than in the Low Psychasthenia group, especially one hour after 300 mg amobarbital.

This is a preview of subscription content, log in to check access.

References

  1. Carlsson, A.: Biochemical pharmacology of amphetamine. In Symposium on abuse of central stimulants. Stockholm: Almqvist and Wiksell 1968.

  2. Cattell, R. B.: Personality and motivation, structure and measurement. New York: World Book 1957.

  3. Costello, C. G.: The effects of depressant and stimulant drugs on the relationship between reaction time and stimulus light intensity. Brit. J. soc. clin. Psychol. 3, 1–5 (1964).

  4. Di Mascio, A., Buie, D. H.: Psychopharmacology of chlorphentermine and d-amphetamine. Clin. Pharmacol. Ther. 5, 174–184 (1964).

  5. Frankenhaeuser, M., Post, B.: Objective and subjective performance as influenced by drug-induced variations in activation level. Scand. J. Psychol. 7, 168–178 (1966).

  6. Hammer, W., Ideström, C.-M., Sjöqvist, F.: Chemical control of antidepressant drug therapy. Excerpta Med. Internat. Congress Series 122, 301–310 (1966).

  7. Ideström, C.-M.: Flicker-fusion in chronic barbiturate usage. Copenhagen: Munksgaard 1954.

  8. —: The effect of γ-phenyl-propylcarbamate compared with meprobamate and placebo. An experimental psychological study. Psychopharmacologia (Berl.) 3, 15–22 (1962).

  9. —, Cadenius, B.: Time relations of the effects of alcohol compared to placebo. Psychopharmacologia (Berl.) 13, 189–200 (1968).

  10. —, Kahan, E.: Monoaminooxidasinhibitorer. Nord. Med. 65, 201–206 (1961).

  11. — —, Molander, L.: Feniprazin — en efterundersökning. Nord. Med. 70, 1188 to 1194 (1963).

  12. Janke, W.: Experimentelle Untersuchungen zur Abhängigkeit der Wirkung psychotroper Substanzen von Persönlichkeitsmerkmalen. Frankfurt am Main: Akad. Verlagsges. 1964.

  13. Jonsson, C.-O., Sjöberg, L., Vallbo, S.: Studies in the psychological effects of a new drug (Diethylpropion). Rep. Psychol. Lab., Univ. Stockholm, No 174 (1964).

  14. King, H. E.: Psychomotor aspects of nervous disease. Cambridge: Harvard University Press 1954.

  15. Klerman, G. L., Di Mascio, A., Greenblatt, M., Rinkel, M.: The influence of specific personality patterns on the reactions to phenotropic agents. In: Masserman, J. H. (Ed.): Biological Psychiatry. New York: Greene and Stratton 1959.

  16. Kornetsky, C., Humphries, E. V.: Relationship between effects of a number of centrally acting drugs and personality. Arch. Neurol. Psychiat. (Chic.) 77 325–327 (1957).

  17. Lindemann, E., Felsinger, J. M. von: Drug effects and personality theory. Psychopharmacologia (Berl.) 2, 69–92 (1961).

  18. Milfeldt, M.: Flicker-fusion in neurology. Århus: Universitetsförlaget 1957.

  19. Pichot, P.: Structure de la personnalité et appréciation des modifications psychologiques produites par les drogues psychotropes. Rev. Psychol. appl. 11, 353 to 360 (1961).

  20. Rinkel, M. (Ed.): Specific and non-specific factors in psychopharmacology. New York: Philosophical Library 1963.

  21. Schalling, D.: Tolerance for experimentally induced pain as related to personality. Manuscript (1970).

  22. - Ideström, C.-M.: Personality and drug effects. Changes in objective tests one and two hours after dexamphetamine and amobarbital in two groups differing in personality. Manuscript (1969).

  23. Schalling, D., Rosén, A.-S.: Personality correlates to Stroop test performance of criminals referred for forensic psychiatric examination. Manuscript (1969).

  24. - Rissler, A., Edman, G.: Pain tolerance, personality and autonomic indices. Manuscript (1970).

  25. Talland, G. A., Quarton, G. C.: Methamphetamine and pentobarbital effects on human motor performance. Psychopharmacologia (Berl.) 8, 241–250 (1965).

  26. Trouton, D., Eysenck, H. J.: The effects of drugs on behaviour. In: Eysenck, H. J. (Ed.): Handbook of abnormal psychology. New York: Basic Books 1961.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ideström, C.-., Schalling, D. Objective effects of dexamphetamine and amobarbital and their relations to psychasthenic personality traits. Psychopharmacologia 17, 399–413 (1970). https://doi.org/10.1007/BF00403811

Download citation

Key-Words

  • Dexamphetamine
  • Amobarbital
  • Cardiovascular Measures
  • Psychological Tests
  • Personality
  • Psychasthenia